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SAINT LOUIS UNIVERSITY SCHOOL OF LAW

SHOULD FOREIGN SALES EXHAUST U.S. PATENT RIGHTS POST
QUANTA?
INTRODUCTION
In 1947, intellectual property made up less than ten percent of U.S.
exports, but by the mid-1990’s intellectual property grew to account for over
fifty percent of all U.S. exports.1 As the world has become flatter in terms of
international trade,2 the exportation of intellectual property in the form of
foreign sales of articles embodying U.S. patents and international technology
licenses has grown substantially. In 2004, royalties and licensing fees
accounted for approximately $52.6 billion worth of payments into the United
States from abroad.3 As these international sales and licenses have grown, it is
now more important than ever for patent holders to have a clear understanding
of how these international sales and licenses affect their patent rights within
the United States when products embodying their patent are imported from
abroad into the United States.
Under the doctrine of patent exhaustion, if a patent holder sells a product
that substantially embodies a patent, the patent holder’s right to restrict the use
of the good is exhausted.4 As stated by the Supreme Court in Chaffee v.
Boston Belting Co.:

1. FRED WARSHOF SKY, THE PATENT WARS 6 (1994)), available at http://jtlp.org/vol1/
gikkas.html; Nicolas S. Gikkas, International Licensing of Intellectual Property: The Promise
and the Peril, 1 J. TECH. L. & POL’Y 6, ¶ 2 (1996) (citing U.S. CENSUS BUREAU, U.S. DEP’T
COMMERCE, STATISTICAL ABSTRACT OF THE UNITED STATES 1951 (1952)).
2. See THOMAS L. FRIEDMAN, THE WORLD IS FLAT: A BRIEF HISTORY OF THE TWENTYFIRST CENTURY 217 (2005) (explaining that in a flattened world companies can do one of three
things with an innovation: patent the invention and sell it themselves, patent the invention and
license it to someone else to manufacture, or patent the invention and cross-license it with other
companies “so that they all have freedom of action to make a product—like a PC—that comes
from melding many different patents”).
3. DANIEL C.K. CHOW & THOMAS J. SCHOENBAUM, INTERNATIONAL TRADE LAW:
PROBLEMS, CASES, AND MATERIALS 17 (2008) (from 1995 through 2004 the receipt of payments
into the United States in international trade in the form of royalties and licensing fees has grown
from $30.3 billion per year to $52.6 billion per year).
4. United States v. Univis Lens Co., 316 U.S. 241, 249 (1942) (“An incident to the
purchase of any article, whether patented or unpatented, is the right to use and sell it, and upon
familiar principles the authorized sale of an article which is capable of use only in practicing the
patent is a relinquishment of the patent monopoly with respect to the article sold.”).
713
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By a valid sale and purchase, the patented machine becomes the private
individual property of the purchaser, and is no longer protected by the laws of
the United States, but by the laws of the state in which it is situated. Hence it
is obvious, that if a person legally acquires a title to that which is the subject of
letters patent, he may continue to use it until it is worn out, or he may repair it
or improve upon it, as he pleases, in the same manner as if dealing with
5
property of any other kind.

In addition to situations where the patent holder sells an article embodying a
patent, the doctrine of patent exhaustion also applies when an authorized
licensee sells such an article.6 In a line of cases following Jazz Photo Corp. v.
International Trade Commission,7 the Court of Appeals for the Federal Circuit
has consistently held that foreign sales of products covered by a U.S. patent do
not exhaust the patent holder’s U.S. patent rights with respect to those
products.8
In general, the Federal Circuit has been relatively liberal in finding that
patent holders could prevent the exhaustion of their patent rights by various
means.9 In Quanta Computer, Inc. v. LG Electronics, Inc., the United States
Supreme Court began a trend of reeling in the expansion of these methods of
preventing patent exhaustion.10 Following this trend, on March 13, 2009,
Northern District of California Judge Claudia Wilken ruled that U.S. patent
rights were exhausted by foreign sales or licenses in the case of LG
Electronics, Inc. v. Hitachi, Ltd.11
While the LG Electronics, Inc. decision is not binding in other
jurisdictions, it does exemplify the trend of restricting the ability of patent
holders to prevent the exhaustion of patent rights after selling articles
embodying their patents.12 Still, this decision flies in the face of the precedent

5. 63 U.S. (22 How.) 217, 223 (1859).
6. Intel Corp. v. ULSI Sys. Tech., Inc., 995 F.2d 1566, 1568 (Fed. Cir. 1993) (explaining
that the doctrine of patent exhaustion “applies similarly to a sale of a patented product
manufactured by a licensee acting within the scope of its license”).
7. 264 F.3d 1094,1105 (Fed. Cir. 2001) (“United States patent rights are not exhausted by
products of foreign provenance.”).
8. See, e.g., Fuji Photo Film Co. v. Jazz Photo Corp., 394 F.3d 1368, 1376 (Fed. Cir. 2005)
(“The patentee’s authorization of an international first sale does not affect exhaustion of that
patentee’s rights in the United States.”).
9. See, e.g., Monsanto Co. v. Scruggs, 459 F.3d 1328, 1336 (Fed. Cir. 2006) (concluding
that when a licensed manufacturer sold patented genetically modified seeds to unauthorized
farmers such sales were unauthorized, thus avoiding exhaustion of the patent holder’s rights);
Mallinckrodt, Inc. v. Medipart, Inc., 976 F.2d 700, 701 (Fed. Cir. 1992) (concluding that a patent
was not exhausted when a “single use only” notice was affixed to the article being sold).
10. 553 U.S. 617, 638 (2008).
11. 655 F. Supp. 2d 1036, 1047 (N.D. Cal. 2009).
12. See Quanta Computer, Inc., 553 U.S. at 621 (holding that the exhaustion doctrine is
applicable to method patents and therefore an authorized sale will exhaust the patent); Static
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previously established by the Federal Circuit.13 The court in LG Electronics,
Inc., in interpreting the Quanta decision, found the Supreme Court was
“unequivocal in stating that the ‘authorized sale of an article that substantially
embodies a patent exhausts the patent holder’s rights and prevents the patent
holder from invoking patent law to control postsale use of the article.’”14 In
noting that “authorized sale” could be interpreted broadly to include
“authorized foreign sales,” the LG Electronics, Inc. Court found that the
authorized foreign sale of articles embodying U.S. patents exhausted the patent
holder’s U.S. patent rights on those articles.15 Such a line of reasoning would
therefore imply that the Supreme Court in Quanta was in effect overruling the
Federal Circuit decisions in the Jazz Photo line of cases sub silentio.
Still, at least one other district has chosen not to apply LG Electronics,
Inc., instead continuing to follow the Federal Circuit’s holding in Jazz Photo.16
These holdings have created a split in how U.S. patent rights are treated when
products are sold or licensed abroad. Such district splits create confusion in
the law; allowing an issue that should be handled uniformly throughout the
U.S. court systems to instead be decided by what district the case is filed in.
Therefore, the question of whether foreign sales exhaust U.S. patent rights is
ripe for review by the appellate courts. In light of this split between districts,
the Federal Circuit or the Supreme Court needs to clarify whether foreign sales
or licenses exhaust U.S. patents.
This paper will argue that not only does this district split need to be
addressed, but also, that foreign sales and licenses should not be found to
exhaust U.S. patent rights. There are valid arguments as to why foreign sales
should exhaust a U.S. patent holder’s rights in articles that the patent holder
authorized to be sold abroad, but there are even stronger policy reasons as to
why such sales should not exhaust U.S. patents.
Part I of this paper will provide a history on the development of the
doctrine of patent exhaustion. In Part II, this paper will review the treatment of
patent exhaustion for articles sold abroad. Part III will discuss the need for
appellate review to clarify this area of law. Finally, in Part IV, this paper will
argue that foreign sales and licenses should not exhaust a U.S. patent.

Control Components, Inc. v. Lexmark Int’l, Inc, 615 F. Supp. 2d 575, 582 (E.D. Ky. 2009)
(holding that post-sale restrictions based in patent law are not enforceable).
13. See, e.g., Jazz Photo Corp. v. Int’l Trade Comm’n, 264 F.3d 1094, 1105 (Fed. Cir. 2001).
14. LG Elecs., Inc., 655 F. Supp. 2d at 1044 (quoting Quanta Computer, Inc., 553 U.S. at
638).
15. Id.
16. Fujifilm Corp. v. Benun, No. 05-cv-1863 (KSH), 2009 WL 2232523, at *3 (D.N.J. July
24, 2009).
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I. THE HISTORY AND DEVELOPMENT OF THE DOCTRINE OF PATENT EXHAUSTION
A.

Development of the doctrine of patent exhaustion

Under 35 U.S.C. § 271, U.S. patent law provides patent holders the
exclusive rights to make, use, or sell any patented invention within the United
States.17 If taken literally this statute would prevent a purchaser from
repairing, reselling, or even using an article embodying an invention without
permission from the patent holder, even if the article was purchased directly
from the patent holder.18 To prevent such a result, the judiciary developed a
doctrine whereby the patent holder’s rights in an article are exhausted by the
authorized sale of such an article.
The origin of the patent exhaustion doctrine can be traced to Bloomer v.
McQuewan.19 In Bloomer, the defendants in the patent infringement case
obtained a license from the patentee to make and use patented machines for the
duration of the patent term.20 At some point after this license was granted, but
prior to the patent’s expiration, Congress extended the statutory length of
patent terms.21 The defendant license holder thus sought to continue using the
licenses through the extended term, while the patent holder tried to restrict the
length of the license to the original patent term.22 The Supreme Court held that
when the machines were licensed or sold to a purchaser they were “no longer
within the limits of the [patent] monopoly” and were instead “private,
individual property” no longer protected by the U.S. patent laws.23
In Chaffee v. Boston Belting Co., the inventor of an improved process to
manufacture rubber assigned the rights to the patent to an assignee.24 The
assignee brought a patent infringement lawsuit against defendants who claimed
that they had previously received a license from the original patent holder.25
The lower court found for the defendants based on the legal standard that a
purchaser of machinery had the right to continue to the use of the machinery in

17. 35 U.S.C. § 271(a) (2006) (“Except as otherwise provided in this title, whoever without
authority makes, uses, offers to sell, or sells any patented invention, within the United States or
imports into the United States any patented invention during the term of the patent therefore,
infringes the patent.”).
18. See id.
19. 55 U.S. (14 How.) 539 (1852).
20. Id. at 547. Patents only provide the patent holder exclusive use of an invention for a
limited term. The current term for a U.S. patent is twenty years from the filing date of an
application. 35 U.S.C. § 154(a)(2) (2006).
21. Bloomer, 55 U.S. (14 How.) at 547.
22. Id. at 548.
23. Id. at 549–50.
24. 63 U.S. (22 How.) 217, 219–20 (1859).
25. Id. at 220.
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conformity with the sale terms.26 The Supreme Court upheld the doctrine that
the valid purchase of a patented article made that article the private property of
the purchaser and stripped the patent holder of any rights in that article.27 Still,
the Court reversed the lower court decision, finding that there had been an
improper assumption that the defendants had obtained any license in the first
place, as there was no evidence provided to support the contention that the
defendant had purchased such rights.28 With this holding the Court added to
what is now known as the doctrine of exhaustion by emphasizing that the
patented article must have been rightfully passed to the purchaser from “the
patentee, or from any other person by him authorized to convey it.”29
Over time the Federal Circuit had allowed the patent holders to use various
means to prevent their patents from being exhausted through the sale of articles
embodying them. In Mallinckrodt, Inc. v. Medipart, Inc.,30 the Federal Circuit
found that when medical devices with a “single use only” notice inscribed on
them were sold, the patent covering the devices was not exhausted as towards
the devices being reusable.31 The court found that if a patented product was
used in violation of a valid restriction the patent holder could seek a remedy
under patent law.32
In Monsanto v. Scruggs, the holder of patents for genetically modified
soybean and cotton licensed their patents to seed manufacturing companies.33
The licensing agreement required that the seeds could only be sold to farmers
who had signed licensing agreements of their own, agreeing not to retain seeds
from one generation of crops to plant in subsequent crops.34 When a farmer
who had not signed an agreement was sued by the patent holder for retaining
the seeds from his crops,35 the Federal Circuit found that the patent was not

26. Id. at 221.
27. Id. at 223.
28. Id. at 222–23.
29. Chaffee, 63 U.S. (22 How.) at 223.
30. 976 F.2d 700 (Fed. Cir. 1992).
31. Id. at 701, 709.
32. Id. at 709 (“If the sale . . . was validly conditioned under the applicable law such as the
law governing sales and licenses, and if the restriction on reuse was within the scope of the patent
grant or otherwise justified, then violation of the restriction may be remedied by action for patent
infringement.”). See also id. at 703 (“This right to exclude may be waived in whole or in part.
The conditions of such waiver are subject to patent, contract, anti-trust, and any other applicable
law, as well as equitable considerations such as are reflected in the law of patent misuse. As in
other areas of commerce, private parties may contract as they choose, provided that no law is
violated thereby.”).
33. 459 F.3d 1328, 1333 (Fed. Cir. 2006).
34. Id.
35. Id.

SAINT LOUIS UNIVERSITY SCHOOL OF LAW

718

SAINT LOUIS UNIVERSITY LAW JOURNAL

[Vol. 55:713

exhausted as the seed companies were not authorized to sell seeds to the farmer
without obtaining a signed licensing agreement from the farmer.36
B.

Quanta Computer Inc. v. LG Electronics Inc.: Pulling Back the Protection
From Patent Exhaustion

In Quanta Computer, Inc. v. LG Electronics, Inc., the United States
Supreme Court pulled back some of the protections against patent
exhaustion.37 In Quanta, the owner of patents for various methods of
computer processing attempted to prevent their patents from being exhausted
when Intel—an authorized licensee—sold computer chips that embodied the
patents to third party computer manufacturers.38 Intel’s licensing agreement
with the patent holder contained a clause explicitly disclaiming the grant of
any implied license to Intel’s customers who purchased the chips.39 Further,
under the terms of its license, Intel was required to inform its customers that
the purchase of the computer chips did not create an implied license to
combine the chips with other computer components as to practice the patent.40
When the patent holder sued the third party computer manufacturers, the
defendant computer manufacturers claimed that the patent was exhausted since
they had purchased the chips from a licensed manufacturer.41 The patent
holder contended its method patent could not be exhausted with the purchase
of the computer chips since the subject of the patent was for a method of
performing computing processes rather than the device performing it.42
Further, the plaintiff patent holder claimed that its patent could not be
exhausted because their licensing agreement with Intel explicitly denied the
grant of any implied license to third party purchasers.43
When the patent holder brought the infringement suit, the district court
granted summary judgment for the defendants, finding that the license to Intel
resulted in patent exhaustion for computer chips legitimately purchased from
Intel.44 In a subsequent order, the district court limited its summary judgment
ruling, finding that patent exhaustion did not apply to process or method claims
that describe operations to make or use a product.45 Upon appeal, the Federal

36. Id. at 1336.
37. 553 U.S. 617 (2008).
38. Id. at 623–24.
39. Id.
40. Id.
41. Id. at 624, 628.
42. Quanta Computer, Inc., 553 U.S. at 628.
43. Id. at 636.
44. LG Elecs., Inc. v. Asustek Computer, Inc., 65 U.S.P.Q. 2d (BNA) 1588, 1601 (N.D.
Cal. 2002), rev’d, 453 F.3d 1364 (Fed. Cir. 2006), rev’d, 553 U.S. 617 (2008).
45. LG Elecs., Inc. v. Asustek Computer, Inc., 248 F. Supp. 2d 912, 918 (N.D. Cal. 2003),
rev’d, 453 F.3d 1364 (Fed. Cir. 2006), rev’d, 553 U.S. 617 (2008).
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Circuit confirmed the district court ruling that the doctrine of patent exhaustion
did not apply to method claims and reversed the lower court in finding that the
patent holder’s patents were not exhausted, as the components were not being
used in the manner authorized within the licensing agreement.46
The Supreme Court found that a method patent was indeed exhausted by
the authorized purchase of an article embodying the patent.47 Further, the
Court found that the license agreement did not actually impose any conditions
on the sale of the chips to the third party computer manufacturers.48 The Court
pointed out that nothing in the license agreement restricted Intel from selling
the computer chips to computer manufacturers intending to practice the
patent.49 While the license agreement stipulated that purchasers of the
computer chips were not receiving an implied licensed to practice the patent,
the Court held that whether these purchasers received an implied license was
irrelevant since the third party purchasers’ right to practice the patent was
based on patent exhaustion rather than an implied license.50 As a result, even
in the absence of an implied license, the authorized sale of the computer chips
embodying the patented method was found to have exhausted the patents.51
II. PATENT EXHAUSTION AND FOREIGN SALES
A.

Prior Rulings on the Effect of Foreign Sales on Patent Exhaustion

The grandfather of patent of cases holding that sales outside of the United
States do not exhaust U.S. patents is the 1890 Supreme Court case, Boesch v.
Graff.52 Boesch was a patent infringement case where a patent holder sued an
importer of infringing gas lamps purchased in Germany.53 The patent holder
held a patent in Germany, but the Imperial Patent Law of Germany at the time
allowed that if a person was already using or preparing to use an invention at
the time the application for the patent was applied for, that person could

46. LG Elecs., Inc. v. Bizcom Elec., Inc., 453 F.3d 1364, 1369–70 (Fed. Cir. 2006).
47. Quanta Computer, Inc., 553 U.S. at 628–29. An article was described as embodying a
method patent when there would be no use for the article other than to practice the patented
method. Id. at 631 (citing United States v. Univis Lens Co., 316 U.S. 241, 249 (1942)).
48. Id. at 636–37 (“Nothing in the License Agreement restricts Intel’s right to sell its
microprocessors and chipsets to purchasers who intend to combine them with non-Intel parts. It
broadly permits Intel to ‘make, use, [or] sell’ products free of LGE’s patent claims. . . . Hence,
Intel’s authority to sell its products embodying the LGE Patents was not conditioned . . . on
Quanta’s decision to abide by LGE’s directions in that notice.”) (citation omitted).
49. Id. at 636.
50. Id. at 637.
51. Id.
52. 133 U.S. 697, 703 (1890).
53. Id. at 698–99.
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continue to use the invention without regard to the patent.54 As such, a
German competitor was authorized to make and sell the otherwise infringing
gas lamps, as they had made preparations to manufacture the gas lamps prior to
the patent holder’s filing of the application.55 The importer of the gas lamps
contended that since his purchase of the gas lamps was authorized under
German law that he was not infringing the patent holder’s rights by importing
the gas lamps into the United States to resell.56
The Court addressed whether an importer could purchase articles subject to
a U.S. patent in another country, from a person authorized by law to sell the
articles there, and then import them to the United States without the consent of
the U.S. patent holder.57 The Court found that such an act infringed the U.S.
patent, holding that “[t]he sale of articles in the United States under a United
States patent cannot be controlled by foreign laws.”58 Whether this holding
was limited to its facts in terms of the original sale being authorized by the
foreign country’s law, but not the patent holder, was not entirely clear.59
The Jazz Photo line of cases represents the modern view on whether
foreign sales exhaust U.S. patent rights.60 The cases revolved around whether
it was patent infringement for companies to refurbish in foreign facilities
patented single-use, disposable cameras after they had been used by customers
and import them into the United States to sell.61 The companies refurbishing
these cameras claimed that the patents on the cameras had been exhausted
through their first sale and that they were merely performing permissible
The patent holders claimed that there was impermissible
repair.62
54. Id. at 701.
55. Id. at 701–02.
56. Id. at 699.
57. Boesch, 133 U.S. at 702–03.
58. Id. at 703.
59. Prior to being clarified by the Federal Circuit, courts had gone both ways. See, e.g.,
Griffin v. Keystone Mushroom Farm, Inc., 453 F. Supp. 1283, 1286–87 (E.D. Pa. 1978) (finding
that foreign sales failed to exhaust a patent holders U.S. patent rights, even if the sale was made
by the patent holder or an authorized licensee of the patent holder). But see Curtiss Aeroplane &
Motor Corp. v. United Aircraft Eng’g Corp., 266 F. 71, 78 (2d Cir. 1920) (finding that if the
patent holder sells a patented article, “that article is freed from the monopoly of any patents which
the vendor may possess,” regardless of whether the sale was made in the United States or abroad);
Kabushiki Kaisha Hattori Seiko v. Refac Tech. Dev. Corp., 690 F. Supp. 1339, 1342 (S.D.N.Y.
1988) (finding no infringement where defendant purchased patented articles outside of the United
States from authorized licensee).
60. See Fuji Photo Film Co., v. Benun, 463 F.3d 1252, 1253–54 (Fed. Cir. 2006); Jazz Photo
Corp. v. United States (Jazz IV), 439 F.3d 1344, 1346–47, 1350 (Fed. Cir. 2006); Fuji Photo Film
Co. v. Jazz Photo Corp. (Jazz III), 394 F.3d 1368, 1371, 1376–77 (Fed. Cir. 2005); Fuji Photo
Film Co., v. Int’l Trade Comm’n (Jazz II), 386 F.3d 1095, 1097–98 (Fed. Cir. 2004); Jazz Photo
Corp. v. Int’l Trade Comm’n (Jazz I), 264 F.3d 1094, 1098, 1105 (Fed. Cir. 2001).
61. See, e.g., Jazz I, 264 F.3d at 1098.
62. Id. at 1101.
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reconstruction63 and even if the refurbishment was permissible that there was
an implied license that the cameras were for a single use only.64
The Federal Circuit found that with respect to cameras originally sold in
the United States, the patent was exhausted.65 Citing Boesch, the court held
that under the doctrine of patent exhaustion, the authorized first sale of the
good “must have occurred under the United States patent.”66 Therefore, for
any cameras whose original sale was outside of the United States, the patent
holder’s U.S. patent rights were not exhausted and any importation of such a
camera was an infringing act.67
B.

LG Electronics, Inc. v. Hitachi, Ltd.: One Federal District Court’s View
of the Effect of Foreign Sales on Patent Exhaustion Post-Quanta

Following the Supreme Courts holding in Quanta, multiple district courts
have taken the Quanta decision as a signal to reel in exceptions to the doctrine
of patent exhaustion.68 In LG Electronics, Inc. v. Hitachi, Ltd., the United
States District Court for the Northern District of California applied the trend of
reducing exceptions to the doctrine of patent exhaustion to articles licensed or
sold outside of the United States.69
LG Electronics, Inc. was essentially a continuation of the litigation
described earlier in Quanta. LG Electronics, Inc., involved the same plaintiff
and essentially the same facts as in Quanta.70 Although the some of the

63. See id. For an example of a case where patent holder argued impermissible
reconstruction, see Aro Manufacturing Co. v. Convertible Top Replacement Co., 365 U.S. 336,
346 (1961) (“The decisions of this Court require the conclusion that reconstruction of a patented
entity, comprised of unpatented elements, is limited to such a true reconstruction of the entity as
to ‘in fact make a new article’. . . . Mere replacement of individual unpatented parts, one at a
time, whether of the same part repeatedly or different parts successively, is no more than the
lawful right of the owner to repair his property.”) (citation omitted).
64. Jazz I, 264 F.3d at 1107.
65. Id. at 1105.
66. Id. (citing Boesch v. Graff, 133 U.S. 697, 701–03 (1890)).
67. Id.
68. See, e.g., LG Elecs., Inc. v. Hitachi, Ltd., 655 F. Supp. 2d 1036, 1046 (N.D. Cal. 2009)
(finding Quanta foreclosed the Fuji Photo exception that patents were not exhausted by an
authorized foreign sale); Static Control Components, Inc. v. Lexmark Int’l, Inc., 615 F. Supp. 2d
575, 586 (E.D. Ky. 2009) (finding that while an earlier Federal Circuit decision found patent
infringement when the patent holder had not yet received its full value of the patent, the Quanta
decision closed this exception; a sale, regardless of whether the patent holder received a full
reward for its product, was unconditional and patent exhaustion applied).
69. LG Elecs., Inc., 655 F. Supp. 2d at 1046.
70. See id. at 1038–39 (“The same patents were the subject of litigation in this Court
between LGE and a number of computer manufacturers. That litigation was eventually appealed
to the United States Supreme Court.”).
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patents involved were different than those in Quanta,71 once again, the patent
holder licensed its patents to Intel under an agreement containing a clause
explicitly disclaiming the grant of any implied license to Intel’s customers.72
Having already lost in Quanta, the plaintiff tried to distinguish the conflict.
The plaintiff argued that because the sales by Intel took place abroad, the first
sale of the components should not have exhausted the U.S. patent rights on
those articles.73 The defendant computer manufacturers contended in return
that Quanta also applied to foreign sales and that even if Quanta did not apply
to foreign sales, the relevant sale took place in the United States, as that was
where the license was entered into.74
In determining whether the U.S. patents were exhausted by the foreign sale
of the components, the court acknowledged that Quanta did not specifically
address whether its holding pertained to foreign sales.75 Still, the court found
that Quanta’s “unequivocal” statement that the “authorized sale of an article
that substantially embodies a patent exhausts the patent holder’s rights and
prevents the patent holder from invoking patent law to control postsale use of
the article” applied to foreign sales.76 Based on the Supreme Court’s rationale
of preventing an “end-run” around the patent exhaustion doctrine, Northern
District of California Judge Claudia Wilken held that the Supreme Court meant
for “authorized sales” to include “authorized foreign sales.”77 In particular, the
court felt that ruling that an authorized foreign sale did not exhaust an article’s
U.S. patent rights would allow a patent holder to reap the benefit of its patent,
yet turn around and sue a downstream purchaser for infringement.78
The court believed that the fact that the Quanta decision discussed foreign
sales in a different context, while failing to separate out foreign sales in its
holding that the authorized sale of the computer chips exhausted the patent
rights in those chips, was evidence of the Supreme Court’s intent that all
authorized sales—whether domestic or foreign—exhaust a patent holder’s

71. Three of the four patents were the same as in Quanta. See id. The fourth patent was
included in the original district court case and Federal Circuit appeal, but was excluded from the
Supreme Court appeal. Id. at 1039.
72. Id. at 1039–40.
73. Id. at 1044. The plaintiff also tried to argue that the articles sold by Intel did not
substantially embody the patent. Id. at 1041–42. This argument was dismissed by the court and
is not relevant to the topic of this paper. See id. at 1044.
74. LG Elecs., Inc., 655 F. Supp. 2d at 1042.
75. Id. at 1044.
76. Id. (quoting Quanta Computer, Inc. v. LG Elecs., Inc., 553 U.S. 617, 638 (2008))
(internal quotation marks omitted).
77. Id. at 1038, 1046–47.
78. Id. at 1046.
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rights.79 The court noted that Boesch was reconcilable with such a holding in
that the sale there was not authorized by the U.S. patent holder.80
In addition to holding that the authorized foreign sale of an article could
exhaust a U.S. patent, the court also found that the location of the authorized
sales was within the United States.81 The court noted that the licensing
agreement with Intel was entered into within the United States and was
governed by New York law.82 As the patent holder received its reward for the
use of the patent when it entered the licensing agreement, the court held that
the licensing agreement was the relevant first sale for the purposes of patent
exhaustion.83 As the licensing agreement was entered into within the United
States, the court found that the relevant sale for patent exhaustion purposes had
occurred within the United States 84
III. THE FEDERAL CIRCUIT OR THE SUPREME COURT NEEDS TO CLARIFY
WHETHER FOREIGN SALES OR LICENSES EXHAUST U.S. PATENTS
While LG Electronics, Inc. v. Hitachi, Ltd. was only a district court case
lacking the precedential effect of an appellate level opinion, there are serious
future implications that arise from the court’s finding that authorized foreign
sales exhaust a U.S. patent holder’s rights. The Northern District of California
is a district with a large patent caseload. During the twelve-month period
ending September 30, 2008, the Northern District of California ranked fifth
among district courts in terms of the highest number of filed patent cases.85 In
addition, the LG Electronics, Inc. ruling on patent exhaustion through foreign
sales has already been cited by courts in other districts.86 An attempt has even

79. LG Elecs., Inc., 655 F. Supp. 2d at 1045 (“[T]he fact that the Court was aware of foreign
sales of the Intel parts, yet declined to limit its holding to sales in the United States, suggests that
interpreting Quanta so as to impose such a limitation would be incorrect.”). The Supreme
Court’s acknowledgement of potential foreign sales was limited to a single footnote, discussing
whether foreign use would be a substantial non-infringing use as part of the discussion as to
whether the article computer chips embodied the method patent. Id. (citing Quanta Computer,
Inc., 553 U.S. at 632 n.6).
80. Id. at 1046–47.
81. Id. at 1048.
82. Id.
83. Id. at 1047–48.
84. LG Elecs., Inc., 655 F. Supp. 2d at 1048.
85. ADMIN. OFFICE OF THE U.S. COURTS, 2008 ANNUAL REPORT OF THE DIRECTOR:
JUDICIAL BUSINESS OF THE UNITED STATES COURTS 192–205 (2009), available at http://www.us
courts.gov/judbus2008/JudicialBusinespdfversion.pdf. Only the District Courts for the Eastern
District of Texas, the Central District of California, District of New Jersey, and District of
Delaware had more cases filed during the twelve-month period ending September 30, 2008. Id. at
194, 197, 201.
86. See, e.g., Static Control Components, Inc. v. Lexmark Int’l., Inc., 615 F. Supp. 2d 575,
588 (E.D. Ky. 2009) (stating that LG Electronics, Inc. v. Hitachi was an example of an expansive
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been made to carry the holding that authorized foreign sales exhaust U.S.
intellectual property rights over into copyright law.87
So far, at least one other district court has declined to follow the Northern
District of California’s lead. In Fujifilm Corp. v. Benun,88 while taking note of
the LG Electronics, Inc. decision, the District of New Jersey found that
because the Supreme Court’s Quanta decision did not specifically address
whether authorized foreign sales could exhaust the patent holder’s U.S. patent
rights, the controlling law on the subject continued to be that of the Jazz Photo
line of cases.89 As such, the District Court of New Jersey held that the foreign
sales of patented articles failed to exhaust the patent holder’s U.S. patent rights
in those articles.90
As it currently stands, there is a split between two of the five most prolific
patent jurisdictions.91 As such, litigants are incentivized to forum shop for
district courts favorable to their case.92 Such a district split creates the type of
confusion and lack of uniformity that led Congress to give the Federal Circuit
appellate jurisdiction over patent cases.93 The confusion over whether or not
foreign sales exhaust U.S. patent rights will likely grow if even more
jurisdictions are asked to consider the issue without further guidance. As such,
either the Federal Circuit or the Supreme Court needs to address this question.

interpretation of Quanta, although patent exhaustion through authorized foreign sales was not at
issue); Fujifilm Corp. v. Benun, No. 05-cv-1863 (KSH), 2009 WL 2232523, at *3 (D.N.J. July
24, 2009) (declining to apply LG Electronics, Inc. noting that it was not controlling law).
87. Brief for eBay Inc. as Amicus Curiae Supporting Petitioner at 8–9, Costco Wholesale
Corp. v. Omega, S.A., 130 S. Ct. 356 (2010) (No. 08-1423), 2009 WL 1759032. Copyright law
recognizes the first sale doctrine, whereby the owner of a lawfully made copy of a copyrighted
article may sell or otherwise dispose of the article. See 17 U.S.C. § 109(a) (2006). The Supreme
Court has held that the importation of a copy of a protected work that was lawfully made within
the United States was allowed under the first sale doctrine, but limited the holding to reimportation of copies made in the United States. See Quality King Distribs. v. L’Anza Research
Int’l, Inc., 523 U.S. 135, 152 (1998).
88. Fujifilm Corp., 2009 WL 2232523. Fujifilm Corp. is yet another entry in the Jazz Photo
line of cases involving disposable cameras. See id. at *1; cf. supra notes 62–63 and
accompanying text.
89. Fujifilm Corp., 2009 WL 2232523, at *3.
90. Id.
91. See ADMIN. OFFICE OF THE U.S. COURTS, supra note 85, at 194, 201.
92. Kimberly A. Moore, Forum Shopping in Patent Cases: Does Geographic Choice Affect
Innovation?, 83 J. PAT. & TRADEMARK OFF. SOC’Y 558, 567 (2001) (explaining that even within
patent law, where the federal courts have exclusive jurisdiction, litigants forum shop for district
courts that are favorable to their argument).
93. See 28 U.S.C. § 1295(a) (2006). See also H.R. REP. NO. 97-312, at 41 (1981)
(“Whatever form such guidelines for particular cases may take, the proposal would continue to
provide a consistent jurisprudence and a uniform body of patent law created over time by the
Court of Appeals for the Federal Circuit or by its reviewing court, the Supreme Court of the
United States.”).
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IV. POLICY REASONS FOR NOT ALLOWING FOREIGN SALES AND LICENSES TO
EXHAUST PATENT RIGHTS
One of the primary policy reasons why foreign sales and licenses should
not exhaust U.S. patents is that the U.S. patent system does not provide for
extraterritorial effects.94 This has two separate effects. First, U.S. patents
provide no protection for articles sold outside of the United States.95 Second,
the inventor must rely on each separate country’s own patent system, under
which the inventor may not have equivalent rights, if he wants protection
outside of the United States.96 Additionally, the established status quo is that
U.S. patent rights are not exhausted by foreign sales, and to move away from
the status quo would disrupt current business practices.
A.

U.S. Patents Provide No Protection for Articles Sold Outside of the
United States

As the court in LG Electronics, Inc. stated, the purpose of the doctrine of
patent exhaustion is to prevent a patent holder from enforcing its patent rights
against downstream purchasers after having already “reap[ed] the benefit of its
patent.”97 The court made a point within its holding to emphasize that the
initial sales of the patented devices were authorized by the U.S. patent holder.
98
As such, the patent holder had reaped its benefit. Still, whether or not the
sale was authorized by the patent holder does not displace the fact that the sale
takes place outside of the jurisdiction of U.S. patent law.
The U.S. patent laws provide that anyone who makes, uses, or sells a
patented invention “within the United States” or imports a patented invention
“into the United States” without the authorization of the patent holder is
infringing the invention.99 It is also infringement to export components or
devices that can only be used to practice a patented invention from the United

94. See Deepsouth Packing Co. v. Laitram Corp., 406 U.S. 518, 531 (1972) (confirming that
the patent system “makes no claim to extraterritorial effect”), abrogated in part by 35 U.S.C. §
271(f) (2006), with respect to components made within the United States for sale abroad that
could only be used to practice an invention protected by a U.S. patent; Rotec Indus., Inc. v.
Mitsubishi Corp., 215 F.3d 1246, 1251 (Fed. Cir. 2000) (quoting Dowagiac Mfg. Co. v. Minn.
Mowline Plow Co., 235 U.S. 641, 650 (1915)) (noting “[t]he right conferred by a patent under
our law is confined to the United States and its territories” and that infringement of U.S. patents
“cannot be predicated on acts wholly done in a foreign country”).
95. Deepsouth Packing Co., 406 U.S. at 531; Rotec Indus., Inc., 215 F.3d at 1251.
96. See Randy L. Campbell, Note, Global Patent Law Harmonization: Benefits and
Implementation, 13 IND. INT’L & COMP. L. REV. 605, 619 (“[W]hat constitutes a patentable
subject matter varies among nations.”).
97. LG Elecs., Inc. v. Hitachi, Ltd., 655 F. Supp. 2d 1036, 1046 (N.D. Cal. 2009).
98. Id. at 1048.
99. 35 U.S.C. § 271(a) (2006).
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States.100 Still, the key to a finding of infringement is that there must have
been an act committed within the United States.
There is no protection from acts committed solely outside of the United
States.101 As such, an article that is manufactured, sold, and used outside of
the United States falls completely outside of the jurisdiction of U.S. patent
laws.102 Therefore, allowing sales outside of the United States to exhaust
United States patents would strip patent holders of a protection that they never
had in the first place.
B.

U.S. Patent Holders May Not Have Equivalent Protection for Their
Invention Abroad

The fact that U.S. patent laws do not provide a patent holder protection
abroad would not be as much of an issue if foreign jurisdictions always
provided U.S. patent holders equivalent protection. As will be discussed, the
rights conferred by foreign jurisdictions may differ substantially.103 Further, it
is possible that the U.S. patent holder will choose not to pursue patent
protection—or may not even be eligible for protection—in these foreign
jurisdictions.104 For sales in a country outside of the United States, the
inventor must avail himself to that country’s applicable patent laws.105 By
virtue of the invention not being protected by U.S. patent laws, the inventor or
his assignee may be dealing from a drastically different bargaining position
when selling their products outside the United States than they would be
dealing from within the United States.106

100. Id. § 271(f).
101. See Deepsouth Packing Co. v. Laitram Corp., 406 U.S. 518, 527 (1972) (citing 35 U.S.C.
§ 271 (1970)).
102. See id. (citing 35 U.S.C. § 271 (1970) (“The statute makes it clear that it is not an
infringement to make or use a patented product outside of the United States.”)); Brown v.
Duchesne, 60 U.S. (19 How.) 183, 195 (1856) (noting U.S. patent laws “do not, and were not
intended to, operate beyond the limits of the United States”).
103. See infra notes 160–81 and accompanying text.
104. See infra notes 113–59 and accompanying text.
105. See Microsoft Corp. v. AT&T Corp., 550 U.S. 437, 455–56 (2007) (holding that AT&T
needed to rely on foreign law to prevent foreign infringement). “Foreign conduct is generally the
domain of foreign law, and in the area here involved, in particular, foreign law may embody
different policy judgments about the relative rights of inventors, competitors, and the public in
patented inventions.” Id. at 455 (internal quotations and citations removed).
106. See Michele L. Vockrodt, Patent Exhaustion And Foreign First Sales: An Analysis And
Application Of the Jazz Photo Decision, 33 AIPLA Q.J. 189, 202 (2005) (quoting Brian D.
Coggio & Adriane M. Antler, The Utilization of the United States Patents to Prevent the Sale of
Gray Goods, 83 TRADEMARK REP. 481, 494 (1993); citing Hilary A. Kremen, Note, Caveat
Venditor: International Application of the First Sale Doctrine, 23 SYRACUSE J. INT’L L. & COM.
161, 163 (1997) (explaining that since patent rights have an “independent territorial existence”
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There is no such thing as an international patent,107 but there are
international treaties that provide requirements for the individual countries’
patent regimes. Most notable are the Paris Convention for the Protection of
Industrial Property (Paris Convention),108 the Agreement on Trade-Related
Intellectual Property Rights (TRIPS),109 and the Patent Cooperation Treaty
(PCT).110
The Paris Convention provided that each member state would grant
equivalent rights for foreign and domestic inventors, give priority rights to
inventors based on the date which they filed a patent application with any other
member state, and adhere to common rules upon contracting member nations’
patent regimes.111 The TRIPS agreement provided general requirements on
each member state’s patent regime in determining standards to apply in
evaluating the patentability of an invention.112 The PCT provided a procedure
for filing patent applications by which inventors could pursue patent protection
with each member state.113
While the PCT made it significantly easier to obtain a patent on an
invention in multiple countries, each country still grants their own patents
subject to their own requirements.114 The PCT allows an applicant to submit a
patent application to one of three international search authorities in what is
called the international stage.115 The international search authority then
performs a search to find prior art that may be relevant to determine whether
an invention is novel, involves an inventive step (is non-obvious), and is
industrially applicable.116 The international search authority then issues a
the bargained for compensation received for the sale an article is “likely to be tailored to the
jurisdiction in which it is sold”)).
107. There is such a thing as a European Patent, but even this is a misnomer. Even with a
European Patent an inventor is required to meet the requirements of the individual nations within
the European Union in which they seek patent protection. Campbell, supra note 96, at 624–25.
108. Paris Convention for the Protection of Industrial Property, Mar. 20, 1883, 21 U.S.T.
1583, 828 U.N.T.S. 305 (as amended on Sept. 28, 1979) [hereinafter Paris Convention].
109. Agreement on Trade Related Intellectual Property Rights, Apr. 15, 1994, Marrakesh
Agreement Establishing the World Trade Organization, Annex 1C, 1869 U.N.T.S. 299
[hereinafter TRIPS].
110. Patent Cooperation Treaty, June 19, 1970, 28 U.S.T. 7645, 1160 U.N.T.S. 231
[hereinafter PCT].
111. See Paris Convention, supra note 108, arts. 2, 4.
112. See TRIPS, supra note 109.
113. See PCT, supra note 110, ch. 1.
114. U.S. PATENT & TRADEMARK OFFICE, U.S. DEP’T OF COMMERCE, MANUAL OF PATENT
EXAMINING PROCEDURE § 1801 (8th ed. 2008) [hereinafter MPEP].
115. See id. § 1801(I) (describing the procedure for Americans that wish to file an
international PCT application). The three international search authorities are the United States
Patent and Trademark Office (USPTO), European Patent Office (EPO), and Korean Intellectual
Property Office (KIPO). Id. §§ 1840–1840.2.
116. PCT, supra note 110, art. 15. MPEP, supra note 114, § 1801(III).
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report on its findings,117 identifying prior art that may prevent the invention
from being patentable within the member states.118
Within thirty months of submitting a PCT application, applicants must
decide whether they wish to enter the national stage in individual countries.119
In the national stage, the application is sent to the different countries where the
applicant wants to obtain a patent for review by each country’s own patent
office.120 Within the national stage the individual countries will weigh the
application under their own rules for patentability.121 The individual countries
may rely on the international search report or may perform prior art searches of
their own.122
As the application is reviewed in each country separately, it can be
extremely costly to seek a patent in multiple countries. Each country will have
its own fees to prosecute a patent.123 The applicant may be required to have
the application translated into that country’s language, as well as conduct the
entirety of the prosecution in that country’s language.124 Further, the applicant
will likely have to hire local representation in each country to argue the merits
of the application.125
Due to these substantial costs, an inventor or an assignee of rights to the
invention may be selective in determining in which countries to seek patents.
It is not out of the realm of possibility that an inventor would not seek a patent
in a country where he would expect only modest sales.126 The lack of a patent
may lead to competition from other manufacturers or producers using the same

117. PCT, supra note 110, art. 18.
118. Id. art. 16, ¶ 1.
119. Id. art. 22, ¶ 1. Article 22 was amended in 2002 to reflect the thirty-month limit.
Revision of the Time Limit for National Stage Commencement in the United States for Patent
Cooperation Treaty Applications, 67 Fed. Reg. 520, 520 (Jan. 4, 2002) (to be codified at 37
C.F.R. pt. 1).
120. See PCT, supra note 110, art. 27 (detailing the requirements for national patent
applications). See also MPEP, supra note 114, § 1893 (describing the advantages over PCT
national stage versus filing an application for a national patent in the United States).
121. PCT, supra note 110, art. 15, ¶ 5(a)–(b), art. 27, ¶ 5.
122. Id. art. 15, ¶ 5(a)–(b).
123. Daniel N. Yannuzzi, Developing a Foreign Filing Strategy, in GLOBAL PATENT
PROSECUTION 111, 117 (Eddie Foumier ed., 2009) (explaining that within each country a part
seeking patent protection will be subject to fees such as “filing fees, examination fees, granting
fees, and annuities or maintenance fees”).
124. Id. (“This means that not only does the initial application need to be translated, but also
subsequent correspondence with the patent office may need to be translated such that the
company and its U.S. attorneys can participate with local foreign counsel in prosecution
activities. These translation fees can be extremely expensive and add dramatically to the cost of
seeking and obtaining patent protection in foreign jurisdictions.”).
125. Id.
126. Id. at 126.
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invention in their products.127 Such competition would be in stark contrast to
the monopoly over the invention given to the patent holder within the United
States. By holding a monopoly on an invention, the patent holder may be able
to charge higher prices when selling its patented products within the United
States; in foreign markets it may be restricted to the price obtainable under
perfect competition.128 If the foreign sale of an article embodying a U.S.
patent is found to exhaust the U.S. patent rights on the article, the door may be
open to disrupt the patent holder’s granted monopoly within the United States.
Foreign resellers and licensees may effectively be able to purchase or contract
for the rights to produce articles in foreign markets at competitive—rather than
monopolistic—prices and then import them into the United States.
Even if a U.S. patent holder were willing to seek patent protection abroad,
it is entirely possible that the invention—patentable within the United States—
would not even be eligible for such protection in other countries. The current
TRIPS regime requires that member countries make patentability available for
inventions “in all fields of technology, provided that they are new, involve an
inventive step and are capable of industrial application.”129 Still, each
country’s patent system has its own requirements for patentability. The
differences between these requirements may seem minor at first, but the devil
may very well be in the details.
One of the most significant differences between various countries’
requirements for patentability is what inventive subject matters are eligible for
patent protection. The areas these differences may be most prevalent in are
computing/business methods and biotechnology. In the United States, 35
U.S.C. § 101 provides a statutory patentable subject matter of “any new and
useful process, machine, manufacture, or composition of matter.”130 The
Supreme Court, in Diamond v. Chakrabarty, interpreted this “to include

127. But see id. (explaining that if a patent protects a product in the American and European
markets it may not be worthwhile for a competitor to enter the market at all).
128. See Alan Devlin & Neel Sukhatme, Self-Realizing Inventions and the Utilitarian
Foundation of Patent Law, 51 WM. & MARY L. REV. 897, 917 (2009) (“An inventor awarded a
patent, in effect, is granted a monopoly over her invention, with the result that consumers cannot
freely avail themselves of its nonrivalrous characteristics. If the technology at issue is sufficiently
valuable—such as if the patented invention is highly useful and has few if any substitutes—the
monopoly that is granted becomes an economic monopoly. As a result, the inventor will set the
price at the point where marginal cost equals marginal revenue and charge a monopoly price,
which exceeds what she would charge in a competitive market.”) (footnotes omitted). See
generally RICHARD A. POSNER, ECONOMIC ANALYSIS OF LAW 273–78 (6th ed. 2003) (detailing
the effects that monopolistic control by a firm has on prices and outputs).
129. TRIPS, supra note 109, art. 27, ¶ 1.
130. 35 U.S.C. § 101 (2006) (“Whoever invents or discovers any new and useful process,
machine, manufacture, or composition of matter, or any new and useful improvement thereof,
may obtain a patent therefor, subject to the conditions and requirements of this title.”).
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anything under the sun that is made by man.”131 While “laws of nature,
physical phenomena, and abstract ideas are not patentable subject matter,”132 a
wide range of computing and business methods133 and biotechnology134
inventions have been granted U.S. patents.
Until recently, business methods and computer software have enjoyed
patentability within the United States so long as they produced a “useful,
concrete, and tangible result.”135 With its ruling in In re Bilski,136 the Federal
Circuit attempted to narrow the patentability of method claims to those
implemented with a particular machine or that transform an article from one
thing or state to another.137 The Supreme Court was critical of this “machineor-transformation test” as “the sole test for deciding whether an invention is a
patent-eligible ‘process.’”138 Still, the Court gave significant credence to the
test by hailing it as a “useful and important clue” in determining
patentability.139

131. 447 U.S. 303, 309 (1980) (quoting S. REP. NO. 1979, at 5 (1952); H.R. REP. NO. 1923, at
6 (1952)).
132. Parker v. Flook, 437 U.S. 584, 598 (1978) (Stewart, J., dissenting).
133. See, e.g., Computer-Based Commc’n Sys. & Method Using Metadata Defining a Control
Structure, U.S. Patent No. 5,862,325 (filed Sept. 27, 1996) (issued Jan. 19, 1999); Method & Sys.
for Generating & Auditing a Signature for a Computer Program, U.S. Patent No. 5,559,884 (filed
June 30, 1994) (issued Sept. 24, 1996); Sys. & Method for Integrating a Bus. Env’t with a Process
Control Env’t, U.S. Patent No. 5,463,555 (filed Sept. 28, 1993) (issued Oct. 31, 1995). But see In
re Bilski, 545 F.3d 943, 956, 964–66 (Fed. Cir. 2008) (rejecting the patentability of a method for
commodity trading and implementing a new standard for patentability of business methods
consisting of evaluating whether a method is tied to a machine or physically transforms an
article).
134. See, e.g., Cancer Susceptibility Mutations of BRCA2, U.S. Patent No. 6,051,379 (filed
Dec. 2, 1997) (issued Apr. 18, 2000); Method for Animal Cell Culture, U.S. Patent No. 5,976,833
(filed Sept. 19, 1996) (issued Nov. 2, 1999); Method of Treating HIV in Humans by Admin. of
DDI & Hydroxycarbamide, U.S. Patent No. 5,521,161 (filed Dec. 20, 1993) (issued May 28,
1996).
135. In re Alappat, 33 F.3d 1526, 1544 (Fed. Cir. 1994), abrogated by In re Bilski, 545 F.3d
at 943 (setting the standard by which the Federal Circuit determined whether a mathematical
concept was patentable prior to In re Bilski). AT&T Corp. v. Excel Commc’ns, Inc., 172 F.3d
1352, 1357–60 (Fed. Cir. 1999), abrogated by In re Bilski, 545 F.3d at 943 (applying the standard
set by in In re Alappat in finding that a mathematical algorithm for use in billing long distance
phone calls was patentable). See also State St. Bank & Trust Co. v. Signature Fin. Grp., Inc., 149
F.3d 1368, 1373–75 (Fed. Cir. 1998), abrogated by In re Bilski, 545 F.3d at 943 (applying the
standard set by In re Alappat in finding that a mathematical algorithm for use in compiling
financial data was patentable).
136. 545 F.3d at 943.
137. Id. at 959–60 (concluding that the “useful, concrete and tangible result” test was
insufficient and that the “machine-or-transformation test” was the correct test to apply in
determining whether business or computational methods were patentable).
138. Bilski v. Kappos, 130 S. Ct. 3218, 3227 (2010).
139. Id.
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Even under the “machine-or-transformation test” for the patentability of
business methods and computer software, the patentability of such inventions
within the United States is still greater than under the patent systems in some
other countries. Much of Europe ties patentability to inventions that actually
make a contribution in a technical field.140 Under such a standard, technology
is frequently restricted to that which is a physical object.141 As such, business
methods and software are generally not patentable in Europe.142 Hostility
toward the patentability of business methods and software is not restricted to
just Europe, as countries like Israel, China, and India also severely restrict such
inventions from being patented.143
Biotechnology is another area that can differ greatly in its patentability
within different patent jurisdictions. While biotechnology is generally
accepted as patentable within the United States, developing countries are
resistant to recognizing intellectual property rights in biotechnology.144 Article
27 of TRIPS provides that all member nations must make patent protection
available in all fields of technology.145 Member countries may exclude from
patentability inventions that which would (1) harm the “ordre public or

140. United Nations Convention on the Grant of European Patents (European Patent
Convention), art. 52(1), Oct. 5, 1973, 1065 U.N.T.S. 255, available at http://www.epo.org/
patents/law/legal-texts/epc.html, as amended by the Act Revising the European Patent
Convention, Nov. 29, 2000. See also RAINER OSTERWALDER, EUROPEAN PATENT OFFICE,
PATENTS FOR SOFTWARE?: EUROPEAN LAW AND PRACTICE 9–11 (2009) (addressing how the
standard for patentability set by the European Patent Convention is applied to software), available
at http://documents.epo.org/projects/babylon/eponet.nsf/0/a0be115260b5ff71c125746d004c51a5/
$FILE/patents_for_software_en.pdf.
141. Kelvin W. Willoughby, How Much Does Technology Really Matter in Patent Law? A
Comparative Analysis of Doctrines of Appropriate Patentable Subject Matter in American and
European Patent Law, 18 FED. CIR. B.J. 63, 95 (2009) (“The EPO’s contribution approach
presumes that an artifact is only ‘technical’ (i.e., a technology) if it is a physical machine, or
perhaps just simply physical.”).
142. See European Patent Convention, supra note 140, art. 52(2)(c) (stating that mathematical
methods, methods for performing mental acts or doing business, and computer programs “shall
not be regarded as inventions within the meaning of paragraph 1” of Article 52.). See also
Willoughby, supra note 141, at 97 (“Software inventions are generally not ‘technical’ according
to this way of thinking. . . . the EPO’s case law has held that if the software is functionally
embedded inside something that will hurt you if you drop it on your foot, then it may be deemed
as ‘technical’ and hence patentable.”).
143. Yannuzzi, supra note 123, at 133.
144. Jonathan Curci, The New Challenges to the International Patentability of Biotechnology:
Legal Relations Between the WTO Treaty on Trade-Related Aspects of Intellectual Property
Rights and the Convention on Biological Diversity, 2 INT’L L. & MGMT. REV. 1, 2 (2005)
(developing countries are resistant to the patentability of biotechnology fearing patentability of
biotechnology results in control by the developed world over their access to “food, medicinal
technology, and other resources essential to mankind’s health and welfare”).
145. TRIPS, supra note 109, art. 27, ¶ 1.
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morality;”146 (2) pertain to “diagnostic, therapeutic and surgical methods for
the treatment of humans or animals;”147 or (3) relate to “plants and animals
other than micro-organisms, and essentially biological processes for the
production of plants or animals other than non-biological and microbiological
processes.”148
The requirement that an invention must be novel in order to be eligible for
a patent is fairly standard both in the United States and abroad. The individual
components of the novelty test within patent laws vary from country to
country, creating circumstances where an invention could be considered
novel—and thus patentable—within the United States, yet fail the novelty
requirement in other countries.
Title 35 U.S.C. § 102 provides a complicated multi-faceted test to
determine whether an invention is novel under U.S. patent law.149 Within the
United States, if “the invention was known or used by others in this country”
then it is deemed to lack novelty.150 This can be better understood as a
requirement that only the first person to invent something is eligible for a
patent on his invention. Notice though, that the resulting first-to-invent patent
system has a territorial element in that a prior invention must have been known
within the United States to defeat an applicant’s novelty.151 Following this
rule, if another inventor were to invent something abroad first, a subsequent
U.S. inventor may still be entitled to a U.S. patent so long as there was no
knowledge of the invention within the United States. Meanwhile, the majority
of other countries have a first-to-file system, awarding patents to the first
inventor to file an application for a patent.152 As such, if a U.S. inventor were
the first to invent something they would be eligible for a U.S. patent, but could
still lose out to a subsequent inventor in foreign countries by losing the race to
file a patent application.
Additionally, if an invention was “patented or described in a printed
publication” anywhere in the world or was “publicly used or sold” within the
United States more than one year prior to the date of filing an application for a
patent, then the invention would fail the novelty test under U.S. patent laws.153
As such, if the invention was publicly disclosed in a printed manner by
anyone—including the inventor applying for the patent—more than a year
before the filing of an application, the invention is not patentable. This creates

146.
147.
148.
149.
150.
151.
152.
153.

Id. art. 27, ¶ 2.
Id. art. 27, ¶ 3(a).
Id. art. 27, ¶ 3(b).
35 U.S.C. § 102 (2006).
Id. § 102(a).
Id.
Campbell, supra note 96, at 619.
35 U.S.C. § 102(b).
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a grace period of one year in which an inventor may apply for a patent after
having already disclosed the invention.154
This one-year grace period is generous compared to many of the patent
systems found in other countries. The Paris Convention prevents member
countries from denying patentability on novelty grounds due to an inventor
having disclosed an invention through the act of filing a patent application in
another member country within the previous twelve months.155 While the
Paris Convention essentially gives a twelve-month grace period for an inventor
who has decided to seek patent protection elsewhere first, this grace period
does not apply to any disclosures preceding the filing of a patent application in
at least one member country.156
Individual countries frequently determine their own rules for inventions
disclosed outside of a patent application. China allows for a six-month grace
period for inventions disclosed at exhibitions sponsored or recognized by the
Chinese Government, made public at prescribed academic or technological
meetings, or disclosed without the consent of the applicant.157 European Patent
Convention countries158 have a strict novelty requirement159and provide a
grace period in such limited situations as to render their grace period virtually

154. Such grace periods are controversial. On one hand, grace periods allow inventors to
share discoveries and interact with others in the field in such a way as to promote innovation and
growth without risk of losing their patent rights. Renee E. Metzler, Comment, Not All Grace
Periods Are Created Equal: Building a Grace Period From the Ground Up, 13 MARQ. INTELL.
PROP. L. REV. 371, 376–77 (2009). On the other hand, grace periods may allow an inventor to
delay their filing of a patent and subsequently increase the duration of time in which they will
have exclusive rights in the invention. See id. at 403 (explaining that an increased grace period
would disrupt the fair balance between an inventor and the public).
155. Paris Convention, supra note 108, art. 4(A), (C)(1) (noting a twelve-month grace period
is given for inventors to seek utility patents in additional countries after having filed an
application in an initial member country; design patents receive only a six-month grace period).
See also Metzler, supra note 154, at 40001 (noting that the Paris Convention most benefits
inventors who disclose their inventions for the first time in the application process).
156. See Metzler, supra note 154, at 401 & n.128 (noting that any disclosures made prior to
the filing of the first patent application could be used against the applicant as prior art).
157. Patent Law of the People’s Republic of China (promulgated by the Standing Comm.
Nat’l People’s Cong., Mar. 12, 1984), as amended by Decision on the Amendment of the Patent
Law of People’s Republic of China (promulgated by the Standing Comm. Nat’l People’s Cong.,
Aug. 25, 2000, effective July 1, 2001) art. 24, translated in 1 P.R.C. LAWS & REGS II-03-03-101
(China).
158. There are currently thirty-six member states of the European Patent Organization. See
Member states of the European Patent Organization, EUROPEAN PATENT ORG., http://www.epo.
org/about-us/organisation/member-states.html (last visited June 20, 2011), for a list of member
countries.
159. European Patent Convention, supra note 140, art. 52(1) (“European patents shall be
granted for any inventions, in all fields of technology, provided that they are new, involve an
inventive step and are susceptible of industrial application.”).
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non-existent.160 In fact, the European Patent Convention specifically includes
“everything made available to the public by means of a written or oral
description, by use, or in any other way” prior to the filing of a European
patent application as novelty defeating art.161
As the novelty requirements vary significantly from country to country it is
entirely possible that an invention that has been publicly disclosed may still be
patentable in the United States due to the twelve-month grace period, yet be
unpatentable due to lack of novelty in a significant portion of the world. As
such, it is not a given that a U.S. patent holder would have any protection for
its intellectual property abroad.
Even if an inventor or his assignee has a patent where the good is sold, the
patent may be more difficult to enforce.162 Therefore, the patent holder may
have substantially less bargaining power. In order to enforce these foreign
patents, the patent holder would still be required to avail themselves to each
separate country’s court system in response to infringing acts within those
jurisdictions.163 If the patent holder has to sue infringers in these various
countries the patent holder will likely need to hire foreign counsel in each
jurisdiction to represent them.164 Further additional cost may be necessary to
translate any court documents and transport key witnesses to the trial
location.165 As the difficulty to enforce a patent increases, the value of the
patent decreases. It is not unlikely that when facing the possibility that a
competitor in a foreign country will infringe a patent, the patent holder may be
better off licensing the patent to this potential infringer rather than trying to
enforce its rights through a foreign country’s courts. In such a situation the
patent holder may be inclined to license the patent at a rate below what the
patent holder would desire in the patent holder’s home jurisdiction.
Additionally, some countries have compulsory licenses and local working
requirements that may reduce a patent holder’s bargaining power. Black’s Law
Dictionary defines compulsory license as “a statutorily created license” that
permits people to pay a royalty and use an invention without the patentee’s
permission.166 Local working requirements are requirements that a patent
holder manufacture or produce a patented article within the granting country’s

160. See Metzler, supra note 154, at 397 n.113 (2009) (discussing that many commentators
have incorrectly reached the conclusion that the EPC does not provide any grace period).
161. European Patent Convention, supra note 140, art. 54(2).
162. Yannuzzi, supra note 123, at 127.
163. Id. at 127–28.
164. Id. at 127 (“It is also desirable to have local U.S. counsel (whether in-house or outside
counsel) help manage foreign counsel and issues associated with the enforcement action.”).
165. Id.
166. BLACK’S LAW DICTIONARY 1003 (Bryan A. Garner ed., 9th ed. 2009).
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territory or otherwise forfeit rights in the patent.167
Local working
requirements and compulsory licenses often work hand-in-hand, as the typical
remedy for failing to practice a local working requirement is to grant of a
compulsory license to a local producer.168 While the United States does not
formally recognize compulsory licenses or working requirements,169 other
countries—particularly developing countries—do contain compulsory licenses
or working requirements within their patent laws.170
The TRIPS Agreement restricts member nations from granting compulsory
licenses, with the exception of specific conditions listed within Article 31.171
Among the conditions listed under Article 31 of the TRIPS agreement are that
compulsory licenses must be considered on each occurrence’s individual
merits, that the proposed grantees of compulsory licenses be required to
attempt to negotiate a license first, that the scope and duration of any
compulsory licenses are limited to the specific purpose for which they were
authorized, that the use of the compulsory licenses are limited to supplying the
granting country’s domestic market, and that adequate remuneration is
167. See Paul Champ & Amir Attaran, Patent Rights and Local Working Under the WTO
TRIPS Agreement: An Analysis of the U.S.-Brazil Patent Dispute, 27 YALE J. INT’L L. 365, 366 &
n.6 (2002) (describing the meaning of local working requirements); see also id. at 37073
(describing the history of the use of local working requirements in the development of patent
laws).
168. Id. at 366.
169. BLACK’S LAW DICTIONARY, supra note 166, at 1003 (“While some nations currently
recognize compulsory licenses, the United States never has.”). Commentators have noted that
judicial remedies such as those imposed on patent holders to cure antitrust violations and awards
of on-going reasonable royalties in lieu of an injunctions as the result of patent infringement
certain cases are essentially compulsory licenses. See, e.g., Joshua D. Sarnoff & Christopher M.
Holman, Recent Developments Affecting the Enforcement, Procurement, and Licensing of
Research Tool Patents, 23 BERKELEY TECH. L.J. 1299, 1353–55 (2008) (noting that ongoing
royalty damage awards offered in lieu of injunctions may be considered compulsory licenses);
Andrew C. Mace, Note, TRIPS, eBay, and Denials of Injunctive Relief: Is Article 31 Compliance
Everything?, 10 COLUM. SCI. & TECH. L. REV. 232, 249–50 (2009) (stating commentators note
that the United States has a long history of granting compulsory licenses in the form of judicial
orders to remedy anti-competitive practices). In addition, where the U.S. government is found to
have infringed a patent, they are only held to damages and fees, essentially equating to a
compulsory license. See 28 U.S.C. § 1498(a) (2006) (providing monetary remedies but no
injunction). See also Richard J. McNeely, Governmental Indirect Patent Infringement: The Need
to Hold Uncle Sam Accountable Under 28 U.S.C. § 1498, 36 CAP. U. L. REV. 1065, 1080 (2008)
(“When the government infringes a patent, the government is viewed to have taken control not of
the patent itself, but of a compulsory license to practice the patented invention.”). The Federal
Circuit has tried to distinguish such remedies, stating that, “‘compulsory license’ implies that
anyone who meets certain criteria has congressional authority to use that which is licensed” as
compared to judicially imposed remedies only pertaining to the parties in suit.” Paice LLC v.
Toyota Motor Corp., 504 F.3d 1293, 1313 n.13 (Fed. Cir. 2007).
170. Champ & Attaran, supra note 167, at 366 & n.7.
171. TRIPS, supra note 109, art. 31.
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awarded to patent holders.172 Article 5A of the Paris Convention offers a few
additional restrictions on the use of compulsory licenses.173 Article 5A
provides that such compulsory licenses cannot be granted prior to four years
from the filing date of a patent application or three years from the patent issue
date, whichever is later; thus allowing a patentee adequate time to attempt to
meet the needs of the market.174 In addition, Article 5A allows a patent holder
to avoid compulsory licenses by showing justification for not meeting the
market demand.175
Local working requirements are generally not accepted within the various
international treaties on patent rights. The Paris Convention disallowed the
forfeiture of patents by member countries purely on the grounds that patented
articles are imported into that country.176 The TRIPs Agreement allows that
“patents shall be available and patent rights enjoyable without discrimination
as to . . . whether products are imported or locally produced.”177 Still, many
developing countries have refused to eliminate their local working
requirements, arguing that the exceptions within the TRIPs agreement and the
Paris Convention for compulsory licenses apply to local working requirements
as well.178
Developing countries are known to use compulsory licenses and local
working requirements to force patent holders to bring their patented products
to market at terms favorable to the public.179 Brazil has repeatedly used the
threat of compulsory licenses to obtain concessions from major pharmaceutical
firms.180 The U.S. Government went so far as to bring a case before the WTO,
challenging Brazil’s patent laws on local working requirements and
compulsory licenses.181 Under international pressure, the U.S. Government
withdrew the case but reserved the right to renew the complaint.182 Brazil has
since carried through on its threat, granting a compulsory license for the
172. Id.
173. Paris Convention, supra note 108, art. 5A.
174. Id. art. 5A(4).
175. Id.
176. Id. art. 5A(1).
177. TRIPS, supra note 109, art. 27, ¶ 1.
178. Champ & Attaran, supra note 167, at 367–68.
179. See Elizabeth Ferrill, Clearing the Swamp for Intellectual Property Harmonization:
Understanding and Appreciating the Barriers to Full TRIPS Compliance for Industrializing and
Non-Industrialized Countries, 15 U. BALT. INTELL. PROP. L.J. 137, 162–63 (2007) (describing
threats to use compulsory licenses by South Africa, Brazil, and Nigeria to obtain concessions
from pharmaceutical companies).
180. Peter K. Yu, Access to Medicines, BRICS Alliances, and Collective Action, 34 AM. J.L.
& MED. 345, 349 (2008).
181. Champ & Attaran, supra note 167, at 365–66.
182. See id. at 366 (noting that the United States stood to lose more by “winning” the
litigation than by abandoning it, and that the United States could still file a new complaint).
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patented drug efavirenz as part of a program to provide free treatment of
HIV/AIDS in 2007.183 While under TRIPs a compulsory license may only be
used domestically,184 the mere possibility that such licenses could be granted
creates incentives for a patent holder to price patented articles for less or accept
less favorable terms when negotiating licenses for their technology.
C. Not Allowing Foreign Sales to Exhaust U.S. Patent Rights is the Status
Quo
A final policy reason why foreign sales should not exhaust U.S. patents is
that such a change would go against the status quo. Allowing the foreign sale
of articles subject to U.S. patents to exhaust U.S. patent rights may directly
interfere with current business models and puts patent holders that have
previously entered into licenses abroad in an unintended position.
One example of a business model which would be affected would be that
of the pharmaceutical industry.
Within this industry, pharmaceutical
companies give away or sell their patented drugs at deeply reduced prices to
third world countries.185 The pharmaceutical companies have the freedom to
do this as most of their costs are incurred in the development of the drugs,
while the marginal cost of producing an additional amount of the drugs is
The pharmaceutical companies recoup their
relatively inexpensive.186
development cost and make their profits though selling their drugs in wealthier
nations.187 Allowing foreign sales of drugs to exhaust the pharmaceutical
companies’ patents could create a secondary market for drugs earmarked to
third world countries to be resold in the United States. The drug companies
would be forced to compete in the U.S. market with their own products,
driving down profits and ultimately the development of future advances in
medicine. Meanwhile, third world populations would be robbed of desperately
needed medicine.
Finally, any change from the status quo would harm patent holders who
previously entered into licenses with the understanding that the articles
produced and sold abroad would not exhaust their U.S. patent rights. Since

183. Yu, supra note 180, at 349.
184. TRIPS, supra note 109, art. 31(f) (indicating that where a compulsory license is
permitted, such use shall be authorized predominately for the domestic market).
185. See Vockrodt, supra note 106, at 205 (“[P]harmaceutical firms often engage in the
practice of international price discrimination. This allows firms to charge higher prices in
lucrative markets, like the United States, to recoup the costs of expensive research and
development, while at the same time providing drugs at lower prices to areas such as sub-Saharan
Africa, where consumers would not otherwise be able to afford them.”) (footnotes omitted).
186. See id. (noting development costs are recouped by charging high prices to citizens of
developed countries, enabling companies to charge lower costs to citizens of third-world
countries).
187. Id.
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Jazz Photo I was decided in 2001, patent holders entering into international
licensing agreements have likely been very much aware that foreign sales did
not exhaust their U.S. patents rights.188 While in both the Jazz Photo and LG
Electronic line of cases the argument that foreign sales should not exhaust U.S.
patents was used as a fall back argument when originally intended methods of
preventing patent exhaustion were invalidated,189 it is foreseeable that some
patent holders may have entered into foreign licenses with the specific
understanding that such licenses would not affect their market within the
United States.
CONCLUSION
As international IP issues are more frequently being litigated due to the
globalization of business and competition, there is a need for clarity on the
issue of the whether the foreign sale of patented goods exhausts the patent
holder’s U.S. patent rights. While the recent Supreme Court decision in
Quanta can be interpreted as reigning in attempts by patent holders to retain
patent rights on articles after such patent holders have already enjoyed the
benefits of their patent through the first sale of such articles, the court did not
specifically address whether foreign sales should exhaust U.S patent rights.190
With LG Electronics, Inc. v. Hitachi, Ltd., at least one district court has found
that Quanta’s attempt to reign in the exceptions to the doctrine of patent
exhaustion applied to foreign sales.191 Still at least one other district court has
found that by failing to address foreign sales, Quanta did not overturn the
controlling precedent as set by the Jazz Photo line of cases.192
There are strong policy reasons as to why upon review of the topic, either
the Federal Circuit or the Supreme Court should find that foreign sales should
not exhaust U.S. patent rights. Even with such a finding, cases like LG
Electronics, Inc. v. Hitachi, Ltd. may not need to be overturned as there may be
further issues as to whether a licensing agreement entered into on U.S. soil,

188. Jazz Photo Corp. v. Int’l Trade Comm’n, 264 F.3d 1094, 1105 (Fed. Cir. 2001) (holding
U.S. patent rights are not exhausted by foreign sales, provided that the first sale of the patent
occurs outside of the United States).
189. Id. at 1101–02 (noting that appellants’ second argument was that the patent right has
been exhausted as to the pertinent articles and that their first argument was that the activity in
question constituted permissible repair rather than impermissible reconstruction); LG Elecs., Inc.
v. Hitachi, Ltd., 655 F. Supp. 2d 1036, 1042 (N.D. Cal. 2009) (noting LG Electronics’ alternative
argument was that even if the parts replaced substantially embody the patents, precedent
regarding exhaustion applies only when the first authorized sale of patented items occurred in the
United States).
190. LG Elecs., Inc., 655 F. Supp. 2d at 1044.
191. Id. at 1047.
192. Fujifilm Corp. v. Benun, No. 05-cv-1863 (KSH), 2009 WL 2232523, at *3 (D.N.J. July
24, 2009).
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controlled by U.S. contract law, and with the benefits reaped within the United
States would constitute an authorized sale under U.S. patent laws.193
JOHN R. SCHROEDER

193. See LG Elecs., Inc., 655 F. Supp. 2d at 1048 (noting that what law applied and in what
country the sale took place would have been issues if LG Electronics had not conceded them).
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